FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W190202823> ?p ?o ?g. }

• W190202823 endingPage "1246" @default.
• W190202823 startingPage "1241" @default.
• W190202823 abstract "Background Direct and indirect evidences have suggested that angiogenesis is a prerequisite for the development of endometriosis. Aiming at offering experimental evidences for anti-angiogenesis therapy, we transplanted the eutopic endometrium from patient with endometriosis into the severe combined immunodeficiency disease (SCID) mice, to evaluate the effect of the endostatin on the growth and angiogenesis of the established endometriosis lesions in SCID mice model. Methods Eutopic endometrium of women with endometriosis was transplanted into the SCID mice. The mice were randomized into treatment (n=10) and control groups (n=10). Two weeks after the implantation of endometrium fragment, the treatment group was injected with recombinant human endostatin YH-16 into the peritoneal cavity (2 mg·kg−1·d−1), whereas the control group received equivalent volume of PBS (200 μl/d). The volume of endometriotic lesions in SCID mice was measured every three days, and all the treatment lasted for 14 days. Immunohistochemistry was used to determine microvessel density (MVD) and the expression of VEGF. The results were analyzed by t test and χ2 test to value the treating effect. Results Compared with the control group, growth of endometriosis lesion was reduced in the mice treated with YH-16. Statistically significant differences in the volume and weight of the ectopic lesions were observed between the treatment and the control groups (P<0.05). Microscopical examination showed that after being treated with YH-16, the volume of the endometrial tissues decreased, the glands depauperated, and the glandular epithelium partially degenerated. Necrotic debris was observed in the endometrial stroma. MVD and expression of VEGF in the treatment group were significantly lower than those in the control group (P<0.05). Conclusions Recombinant human endostatin affects the maintenance and growth of endometriotic tissues by inhibiting angiogenesis and reducing the expression of VEGF in ectopic lesion. The angiostatic agent may be promising as a therapy for endometriosis. Chin Med J 120; 2007 (14):1241–1246" @default.
• W190202823 created "2016-06-24" @default.
• W190202823 creator A5018324791 @default.
• W190202823 creator A5022500932 @default.
• W190202823 creator A5045900984 @default.
• W190202823 date "2007-07-01" @default.
• W190202823 modified "2023-10-17" @default.
• W190202823 title "Effect of recombinant human endostatin on endometriosis in mice" @default.
• W190202823 cites W1502831380 @default.
• W190202823 cites W1579297325 @default.
• W190202823 cites W1972238505 @default.
• W190202823 cites W1985712533 @default.
• W190202823 cites W1994695048 @default.
• W190202823 cites W1996622332 @default.
• W190202823 cites W2000909793 @default.
• W190202823 cites W2000976989 @default.
• W190202823 cites W2001906671 @default.
• W190202823 cites W2005179942 @default.
• W190202823 cites W2041116703 @default.
• W190202823 cites W2056951482 @default.
• W190202823 cites W2059992425 @default.
• W190202823 cites W2060449870 @default.
• W190202823 cites W2064644581 @default.
• W190202823 cites W2078868629 @default.
• W190202823 cites W2086233980 @default.
• W190202823 cites W2105925637 @default.
• W190202823 cites W2129180815 @default.
• W190202823 cites W2131798870 @default.
• W190202823 cites W2135305245 @default.
• W190202823 cites W2137043841 @default.
• W190202823 cites W2140246703 @default.
• W190202823 cites W2160909556 @default.
• W190202823 cites W2163307816 @default.
• W190202823 cites W2203749559 @default.
• W190202823 doi "https://doi.org/10.1097/00029330-200707020-00007" @default.
• W190202823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17697575" @default.
• W190202823 hasPublicationYear "2007" @default.
• W190202823 type Work @default.
• W190202823 sameAs 190202823 @default.
• W190202823 citedByCount "27" @default.
• W190202823 countsByYear W1902028232012 @default.
• W190202823 countsByYear W1902028232013 @default.
• W190202823 countsByYear W1902028232014 @default.
• W190202823 countsByYear W1902028232015 @default.
• W190202823 countsByYear W1902028232017 @default.
• W190202823 countsByYear W1902028232018 @default.
• W190202823 countsByYear W1902028232019 @default.
• W190202823 countsByYear W1902028232021 @default.
• W190202823 countsByYear W1902028232022 @default.
• W190202823 countsByYear W1902028232023 @default.
• W190202823 crossrefType "journal-article" @default.
• W190202823 hasAuthorship W190202823A5018324791 @default.
• W190202823 hasAuthorship W190202823A5022500932 @default.
• W190202823 hasAuthorship W190202823A5045900984 @default.
• W190202823 hasBestOaLocation W1902028231 @default.
• W190202823 hasConcept C126322002 @default.
• W190202823 hasConcept C142724271 @default.
• W190202823 hasConcept C150903083 @default.
• W190202823 hasConcept C16685009 @default.
• W190202823 hasConcept C204232928 @default.
• W190202823 hasConcept C207001950 @default.
• W190202823 hasConcept C2778271429 @default.
• W190202823 hasConcept C2779468541 @default.
• W190202823 hasConcept C2779522080 @default.
• W190202823 hasConcept C2779742232 @default.
• W190202823 hasConcept C2780394083 @default.
• W190202823 hasConcept C2781156865 @default.
• W190202823 hasConcept C71924100 @default.
• W190202823 hasConcept C75920679 @default.
• W190202823 hasConcept C86803240 @default.
• W190202823 hasConceptScore W190202823C126322002 @default.
• W190202823 hasConceptScore W190202823C142724271 @default.
• W190202823 hasConceptScore W190202823C150903083 @default.
• W190202823 hasConceptScore W190202823C16685009 @default.
• W190202823 hasConceptScore W190202823C204232928 @default.
• W190202823 hasConceptScore W190202823C207001950 @default.
• W190202823 hasConceptScore W190202823C2778271429 @default.
• W190202823 hasConceptScore W190202823C2779468541 @default.
• W190202823 hasConceptScore W190202823C2779522080 @default.
• W190202823 hasConceptScore W190202823C2779742232 @default.
• W190202823 hasConceptScore W190202823C2780394083 @default.
• W190202823 hasConceptScore W190202823C2781156865 @default.
• W190202823 hasConceptScore W190202823C71924100 @default.
• W190202823 hasConceptScore W190202823C75920679 @default.
• W190202823 hasConceptScore W190202823C86803240 @default.
• W190202823 hasIssue "14" @default.
• W190202823 hasLocation W1902028231 @default.
• W190202823 hasLocation W1902028232 @default.
• W190202823 hasOpenAccess W190202823 @default.
• W190202823 hasPrimaryLocation W1902028231 @default.
• W190202823 hasRelatedWork W1967114293 @default.
• W190202823 hasRelatedWork W1968854526 @default.
• W190202823 hasRelatedWork W2013823604 @default.
• W190202823 hasRelatedWork W2067901911 @default.
• W190202823 hasRelatedWork W2377971639 @default.
• W190202823 hasRelatedWork W2381411395 @default.
• W190202823 hasRelatedWork W2383296936 @default.
• W190202823 hasRelatedWork W2384976876 @default.

• next